Nucynta 75 MG tablet 100S
Ended Awarded Last action
- Contract number
- SPE2DR26F9KT3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,833
Award facts
- Contract value 100% obligated
- $1,833.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,833.38 to AmerisourceBergen Drug Corp for the supply of Nucynta 75 mg tablets (100 count) on January 12, 2026, with an ultimate completion date of January 13, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award was performed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. Nucynta (tapentadol) is an opioid analgesic used for moderate to severe pain management, and this delivery order represents a routine pharmaceutical procurement to support federal medical supply chain requirements.
This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.9 billion comprehensive pharmaceutical support vehicle running through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds a primary IDC with the Defense Logistics Agency valued at up to $999.9 billion through December 31, 2031, which serves as the foundational vehicle for delivering pharmaceutical products and medical supplies to military treatment facilities and federal healthcare systems worldwide. AmerisourceBergen's contract portfolio demonstrates its established capability as a critical pharmaceutical distributor supporting military healthcare programs with specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F9KT3?
SPE2DR26F9KT3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F9KT3 worth?
The government has obligated $1,833 on SPE2DR26F9KT3.
Is contract SPE2DR26F9KT3 an order under another contract?
Yes. SPE2DR26F9KT3 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KT3 competed?
The extent of competition for SPE2DR26F9KT3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award